International Journal of Pediatrics / 2013 / Article / Tab 2

Clinical Study

Doxapram Use for Apnoea of Prematurity in Neonatal Intensive Care

Table 2

Doxapram data.

(%) Median (IQR) (min–max)

Success rate of doxapram 79/116 (64.8%)
Route of administration (IV/oral/both)58 (49.2)/49 (41.5)/11 (9.3)
Number of doxapram episodes (1/2/3)92 (75.4)/29 (23.8)/1 (0.8)
Postnatal age (days)13.5 (11) (1–40)
Total duration of doxapram use (hrs)108 (147) (0.5–698)
Average dose of doxapram (mg/kg/hour)1.07 (0.66) (0.32–5.44)
Cumulative dose doxapram116 (186) (0.3–859.6)
Cumulative dose doxapram (per kg) 109.5 (174.2) (0.33–781.5)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.